German pharmacies face financial crisis as costs and delays mount

Pharmacies across Germany are struggling with growing financial pressure. Rising costs and delayed payments from health insurers have left many with shrinking cash reserves. As a result, more owners are turning to advance financing options to stay afloat.

The financial squeeze has worsened in recent years. Since 2010, sales of high-cost medications have more than tripled, now making up 40% of the sector's revenue. But the real strain has come from payment delays by health insurance funds, particularly since 2024.

On top of this, energy and staffing costs have climbed, pushing pharmacies to seek faster access to funds. Clearinghouses now offer advance payments on prescription reimbursements, giving pharmacies immediate cash in exchange for fees. The service has grown in popularity, with more owners using it to cover short-term expenses. However, relying too heavily on these early payouts carries risks. While they ease immediate cash flow problems, excessive use could deepen financial instability. Some experts warn that overdependence on such schemes may push pharmacies closer to insolvency.

The trend highlights the growing challenges for German pharmacies. With delayed insurance payments and rising operational costs, many now depend on advance financing to survive. Without changes, the financial strain could force more businesses into difficult positions in the coming years.